Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004602320 | SCV005102112 | uncertain significance | Hereditary cancer-predisposing syndrome | 2024-03-25 | criteria provided, single submitter | clinical testing | The p.P512T variant (also known as c.1534C>A), located in coding exon 9 of the BRCA2 gene, results from a C to A substitution at nucleotide position 1534. The proline at codon 512 is replaced by threonine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on the available evidence, the clinical significance of this alteration remains unclear. |